Lucosky Brookman LLP successfully represented its client, Akers Biosciences, Inc., in connection with a registered public offering of Akers common stock for proceeds of $6 Million.
Lucosky Brookman LLP successfully represented its client, Akers Biosciences, Inc., in connection with a registered public offering of Akers common stock for proceeds of $6 Million.